These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34529241)

  • 41. MRI of pancreatic ductal adenocarcinoma: texture analysis of T2-weighted images for predicting long-term outcome.
    Choi MH; Lee YJ; Yoon SB; Choi JI; Jung SE; Rha SE
    Abdom Radiol (NY); 2019 Jan; 44(1):122-130. PubMed ID: 29980829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of Tumor Progression During Neoadjuvant Chemotherapy and Survival Outcome in Patients With Triple-Negative Breast Cancer.
    Yoen H; Kim SY; Lee DW; Lee HB; Cho N
    Korean J Radiol; 2023 Jul; 24(7):626-639. PubMed ID: 37404105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Features from Computerized Texture Analysis of Breast Cancers at Pretreatment MR Imaging Are Associated with Response to Neoadjuvant Chemotherapy.
    Chamming's F; Ueno Y; Ferré R; Kao E; Jannot AS; Chong J; Omeroglu A; Mesurolle B; Reinhold C; Gallix B
    Radiology; 2018 Feb; 286(2):412-420. PubMed ID: 28980886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Minkowski functionals: An MRI texture analysis tool for determination of the aggressiveness of breast cancer.
    Fox MJ; Gibbs P; Pickles MD
    J Magn Reson Imaging; 2016 Apr; 43(4):903-10. PubMed ID: 26453892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preoperative carboplatin-paclitaxel-bevacizumab in triple-negative breast cancer: final results of the phase II Ca.Pa.Be study.
    Guarneri V; Dieci MV; Bisagni G; Boni C; Cagossi K; Puglisi F; Pecchi A; Piacentini F; Conte P
    Ann Surg Oncol; 2015 Sep; 22(9):2881-7. PubMed ID: 25572687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between rim enhancement of breast cancer on dynamic contrast-enhanced MRI and patient outcome: impact of subtype.
    Schmitz AM; Loo CE; Wesseling J; Pijnappel RM; Gilhuijs KG
    Breast Cancer Res Treat; 2014 Dec; 148(3):541-51. PubMed ID: 25376743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer.
    Onishi N; Sadinski M; Hughes MC; Ko ES; Gibbs P; Gallagher KM; Fung MM; Hunt TJ; Martinez DF; Shukla-Dave A; Morris EA; Sutton EJ
    Breast Cancer Res; 2020 May; 22(1):58. PubMed ID: 32466799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiomics features based on automatic segmented MRI images: Prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemotherapy.
    Ma M; Gan L; Liu Y; Jiang Y; Xin L; Liu Y; Qin N; Cheng Y; Liu Q; Xu L; Zhang Y; Wang X; Zhang X; Ye J; Wang X
    Eur J Radiol; 2022 Jan; 146():110095. PubMed ID: 34890936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinicopathological and prognostic characteristics of triple- negative breast cancer (TNBC) in Chinese patients: a retrospective study.
    Li CY; Zhang S; Zhang XB; Wang P; Hou GF; Zhang J
    Asian Pac J Cancer Prev; 2013; 14(6):3779-84. PubMed ID: 23886182
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intra- and Peritumoral Radiomics Model Based on Early DCE-MRI for Preoperative Prediction of Molecular Subtypes in Invasive Ductal Breast Carcinoma: A Multitask Machine Learning Study.
    Zhang S; Wang X; Yang Z; Zhu Y; Zhao N; Li Y; He J; Sun H; Xie Z
    Front Oncol; 2022; 12():905551. PubMed ID: 35814460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Active behavior of triple-negative breast cancer with adipose tissue invasion: a single center and retrospective review.
    Yamaguchi J; Moriuchi H; Ueda T; Kawashita Y; Hazeyama T; Tateishi M; Aoki S; Uchihashi K; Nakamura M
    BMC Cancer; 2021 Apr; 21(1):434. PubMed ID: 33879104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer.
    Ytre-Hauge S; Dybvik JA; Lundervold A; Salvesen ØO; Krakstad C; Fasmer KE; Werner HM; Ganeshan B; Høivik E; Bjørge L; Trovik J; Haldorsen IS
    J Magn Reson Imaging; 2018 Dec; 48(6):1637-1647. PubMed ID: 30102441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumour heterogeneity revealed by unsupervised decomposition of dynamic contrast-enhanced magnetic resonance imaging is associated with underlying gene expression patterns and poor survival in breast cancer patients.
    Fan M; Xia P; Liu B; Zhang L; Wang Y; Gao X; Li L
    Breast Cancer Res; 2019 Oct; 21(1):112. PubMed ID: 31623683
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy.
    Jalil O; Afaq A; Ganeshan B; Patel UB; Boone D; Endozo R; Groves A; Sizer B; Arulampalam T
    Colorectal Dis; 2017 Apr; 19(4):349-362. PubMed ID: 27538267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictive Clinicopathologic and Dynamic Contrast-Enhanced MRI Findings for Tumor Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
    Eom HJ; Cha JH; Choi WJ; Chae EY; Shin HJ; Kim HH
    AJR Am J Roentgenol; 2017 Jun; 208(6):W225-W230. PubMed ID: 28350486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner.
    Panzironi G; Moffa G; Galati F; Marzocca F; Rizzo V; Pediconi F
    Breast Cancer Res Treat; 2020 May; 181(1):53-60. PubMed ID: 32185587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer.
    Kim S; Kim MJ; Kim EK; Yoon JH; Park VY
    Sci Rep; 2020 Feb; 10(1):3750. PubMed ID: 32111957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional Tumor Volume by Fast Dynamic Contrast-Enhanced MRI for Predicting Neoadjuvant Systemic Therapy Response in Triple-Negative Breast Cancer.
    Musall BC; Abdelhafez AH; Adrada BE; Candelaria RP; Mohamed RMM; Boge M; Le-Petross H; Arribas E; Lane DL; Spak DA; Leung JWT; Hwang KP; Son JB; Elshafeey NA; Mahmoud HS; Wei P; Sun J; Zhang S; White JB; Ravenberg EE; Litton JK; Damodaran S; Thompson AM; Moulder SL; Yang WT; Pagel MD; Rauch GM; Ma J
    J Magn Reson Imaging; 2021 Jul; 54(1):251-260. PubMed ID: 33586845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathological and Imaging Features Predictive of Clinical Outcome in Metaplastic Breast Cancer.
    Yoon GY; Cha JH; Kim HH; Shin HJ; Chae EY; Choi WJ; Oh HY
    Curr Med Imaging; 2020; 16(6):729-738. PubMed ID: 32723245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.